Belgian doctor, researcher and professor, Stéphane De Wit has been with the St Pierre University Hospital in Brussels since 1983. Initially planning…

Ameet Mallik, Executive VP and Head of Oncology for the US at Novartis Oncology highlights the company's culture of 'curious, inspired, and unbossed,'…

Two years on from the introduction of Novartis Oncology’s CAR-T therapy to Europe, Emnuele Ostuni, the firm’s European head of cell and gene…

Emanuele Ostuni, Novartis Oncology’s head of cell and gene therapy for Europe, gives an overview of the introduction of the company’s CAR-T…

Professor Stéphane De Wit, head of the Department of Infectious Diseases at St Pierre University Hospital outlines Belgium’s approach to tackling…

Martin Puchwein, country president for Novartis Group Czech Republic, and general manager for pharma, shares his perspectives on launching innovative…

Pavel Brezina, who led the establishment of Gilead’s affiliate in the Czech Republic and Slovakia seven years ago, shares the amazing journey of…

Dr. Zhang Yu, CEO of Aeon Therapeutics, shares the unique journey that motivated him to establish Aeon Therapeutics, as a joint venture of Chinese…

With proactive government support and an increasingly specialised workforce, China has become one of the leading nations in the development of…

The US FDA has granted orphan drug designation to Shanghai-headquartered biotech CARsgen Therapeutics' CAR-T cell therapy CT053 for multiple myeloma…

Emanuele Ostuni, head of cell & gene therapy for Novartis Oncology in Europe, outlines how stakeholders across the biopharmaceutical value chain…

Medicare, a national health insurance program in the United States covering Americans aged 65 and older as well as younger people with disabilities,…